Line-Field Confocal Optical Coherence Tomography Increases the Diagnostic Accuracy and Confidence for Basal Cell Carcinoma in Equivocal Lesions: A Prospective Study.

basal cell carcinoma bedside histology dermoscopy line-field confocal optical coherence tomography non-invasive diagnostics in dermatology skin imaging

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Feb 2022
Historique:
received: 24 01 2022
revised: 11 02 2022
accepted: 16 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Diagnosing clinically unclear basal cell carcinomas (BCCs) can be challenging. Line-field confocal optical coherence tomography (LC-OCT) is able to display morphological features of BCC subtypes with good histological correlation. The aim of this study was to investigate the accuracy of LC-OCT in diagnosing clinically unsure cases of BCC compared to dermoscopy alone and in distinguishing between superficial BCCs and other BCC subtypes. Moreover, we addressed pitfalls in false positive cases. We prospectively enrolled 182 lesions of 154 patients, referred to our department to confirm or to rule out the diagnosis of BCC. Dermoscopy and LC-OCT images were evaluated by two experts independently. Image quality, LC-OCT patterns and criteria, diagnosis, BCC subtype, and diagnostic confidence were assessed. Sensitivity and specificity of additional LC-OCT were compared to dermoscopy alone for identifying BCC in clinically unclear lesions. In addition, key LC-OCT features to distinguish between BCCs and non-BCCs and to differentiate superficial BCCs from other BCC subtypes were determined by linear regressions. Diagnostic confidence was rated as "high" in only 48% of the lesions with dermoscopy alone compared to 70% with LC-OCT. LC-OCT showed a high sensitivity (98%) and specificity (80%) compared to histology, and these were even higher (100% sensitivity and 97% specificity) in the subgroup of lesions with high diagnostic confidence. Interobserver agreement was nearly perfect (95%). The combination of dermoscopy and LC-OCT reached a sensitivity of 100% and specificity of 81.2% in all cases and increased to sensitivity of 100% and specificity of 94.9% in cases with a high diagnostic confidence. The performance of LC-OCT was influenced by the image quality but not by the anatomical location of the lesion. The most specific morphological LC-OCT criteria in BCCs compared to non-BCCs were: less defined dermoepidermal junction (DEJ), hyporeflective tumor lobules, and dark rim. The most relevant features of the subgroup of superficial BCCs (sBCCs) were: string of pearls pattern and absence of epidermal thinning. Our diagnostic confidence, sensitivity, and specificity in detecting BCCs in the context of clinically equivocal lesions significantly improved using LC-OCT in comparison to dermoscopy only. Operator training for image acquisition is fundamental to achieve the best results. Not only the differential diagnosis of BCC, but also BCC subtyping can be performed at bedside with LC-OCT.

Identifiants

pubmed: 35205830
pii: cancers14041082
doi: 10.3390/cancers14041082
pmc: PMC8870684
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ludwig-Maximilians-Universität München
ID : FöFoLe10-22

Références

Br J Dermatol. 2015 Aug;173(2):428-35
pubmed: 25904111
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e509-e511
pubmed: 33783890
Opt Express. 2020 Mar 16;28(6):7918-7927
pubmed: 32225427
J Dtsch Dermatol Ges. 2019 Feb;17(2):214-230
pubmed: 30762963
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e934-e936
pubmed: 34374136
J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294
pubmed: 32130773
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013191
pubmed: 30521687
J Eur Acad Dermatol Venereol. 2021 May;35(5):1099-1110
pubmed: 33398911
Biomed Opt Express. 2020 Feb 10;11(3):1327-1335
pubmed: 32206413
Skin Res Technol. 2021 May;27(3):340-352
pubmed: 33085784
J Am Acad Dermatol. 2014 Oct;71(4):716-724.e1
pubmed: 24928707
J Am Acad Dermatol. 2010 Jan;62(1):67-75
pubmed: 19828209
Eur J Cancer. 2019 Sep;118:10-34
pubmed: 31288208
Br J Dermatol. 2012 May;166(5):1069-80
pubmed: 22251204
Clin Exp Dermatol. 2021 Dec;46(8):1471-1481
pubmed: 34047380
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013189
pubmed: 30521690

Auteurs

Charlotte Gust (C)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.

Sandra Schuh (S)

Department of Dermatology and Allergy, University Hospital, 86179 Augsburg, Germany.

Julia Welzel (J)

Department of Dermatology and Allergy, University Hospital, 86179 Augsburg, Germany.

Fabia Daxenberger (F)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.

Daniela Hartmann (D)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.

Lars E French (LE)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33125, USA.

Cristel Ruini (C)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.
PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.

Elke C Sattler (EC)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.

Classifications MeSH